Author:
Kaul Kirti,Tarr Joanna M.,Ahmad Shamim I.,Kohner Eva M.,Chibber Rakesh
Reference37 articles.
1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes care 1998; 21(9):1414–1431.
2. WHO. 2011 [cited 2011; available from:
http://www.who.int/diabetes/en/
.
3. Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000; 106(2): 165–169.
4. Phillips JM, Parish NM, Raine T et al. Type 1 diabetes development requires both CD4+ and CD8+ T-cells and can be reversed by non-depleting antibodies targeting both T-cell populations. Rev Diabet Stud 2009; 6(2):97–103.
5. Gorodezky C, Alaez C, Murguía A et al. HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example. autoimmun Eev 2006; 5(3):87–94.
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献